Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHA/603229 stock hub

SHA/603229 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/603229is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.4B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/603229

In the news

Latest news · SHA/603229

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E30.7

P25 17.1P50 24.2P75 37.8

Trailing P/E75.4

P25 23.5P50 41.3P75 83.2

ROE4.6

P25 -0.9P50 4.1P75 8.8

ROIC8.8

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/603229 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

229

Groups with data

Currency

CNY

Showing 229 of 229 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,219
Employees Change	45%
Employees Change Percent	3.83
Enterprise value	CNY 7.7B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100002XK2
Last refreshed	2026-05-10
Market cap	CNY 8.4B
Price	CNY 10.12
Price currency	CNY
Rev Per Employee	652,006.6x
Sector	Healthcare
Sic	2833
Symbol	sha/603229
Website	https://www.ausunpharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.29%
EV Earnings	71.41x
EV/EBIT	54.64x
EV/EBITDA	35.34x
EV/FCF	301.78x
EV/Sales	9.71x
FCF yield	0.3%
Forward P/E	30.67x
P/B ratio	3.54x
P/E ratio	75.37x
P/S ratio	10.55x
PE Ratio10 Y	55.42x
PE Ratio3 Y	38.27x
PE Ratio5 Y	47.86x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.76%
EBITDA Margin	27.46%
FCF margin	3.22%
Gross margin	54.06%
Gross Profit	CNY 429.7M
Gross Profit Growth	-3%
Gross Profit Growth Q	2.94%
Gross Profit Growth3 Y	-0.21%
Gross Profit Growth5 Y	10.28%
Net Income	CNY 108M
Net Income Growth	-49.4%
Net Income Growth Q	-18.91%
Net Income Growth Years	0%
Net Income Growth3 Y	-25.22%
Net Income Growth5 Y	-0.31%
Pretax Margin	13.65%
Profit Margin	13.59%
Profit Per Employee	CNY 88,625
Profitable Years	14
ROA	2.81
Roa5y	4.93
ROCE	5.77
ROE	4.56
Roe5y	11.76
ROIC	8.79
Roic5y	16.86

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	28.2%
Cagr3y	-4.25%
Cagr5y	-1.28%
Div CAGR3	24.32%
Div CAGR5	34.43%
EPS Growth	-47.23
EPS Growth Q	-14.29
EPS Growth Years	0
EPS Growth3 Y	-24.87
EPS Growth5 Y	-1.62
FCF Growth	-9.19%
OCF Growth	-21.28%
OCF Growth10 Y	18.83%
OCF Growth3 Y	-10.48%
OCF Growth5 Y	0.11%
Revenue Growth	-0.78x
Revenue Growth Q	0.66x
Revenue Growth Quarters	2x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.11x
Revenue Growth5 Y	10.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.25
Assets	CNY 3.2B
Cash	CNY 1.2B
Current Assets	CNY 1.9B
Current Liabilities	CNY 711.1M
Debt	CNY 486.2M
Debt EBITDA	CNY 2.23
Debt Equity	CNY 0.21
Debt FCF	CNY 19.02
Equity	CNY 2.4B
Liabilities	CNY 789.7M
Long Term Assets	CNY 1.3B
Long Term Liabilities	CNY 78.6M
Net Cash	CNY 667.4M
Net Cash By Market Cap	CNY 7.96
Net Cash Growth	-18.39%
Net Debt EBITDA	CNY -3.06
Net Debt Equity	CNY -0.28
Net Debt FCF	CNY -26.11
Tangible Book Value	CNY 2.2B
Tangible Book Value Per Share	CNY 2.75
WACC	2.92

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.64
Inventory Turnover	0.97
Net Working Capital	CNY 456.4M
Quick ratio	2.08
Working Capital	CNY 1.2B
Working Capital Turnover	CNY 0.69

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.12%
Dividend Growth	-22.48%
Dividend Growth Years	0%
Dividend per share	CNY 0.1
Dividend Years	8
Dividend Yield	0.99%
Ex Div Date	2025-07-17
Last Dividend	CNY 0.1
Payout Frequency	Annual
Payout Ratio	85.35%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	28.18%
200-day SMA	10.13
3Y total return	-12.22%
50-day SMA	9.78
50-day SMA vs 200-day SMA	50under200
5Y total return	-6.25%
All Time High	34.21
All Time High Change	-70.42%
All Time High Date	2022-05-11
All Time Low	2.2
All Time Low Change	359.58%
All Time Low Date	2018-10-19
ATR	0.34
Beta	-0.21
Beta1y	-0.15
Beta2y	0.3
Ch YTD	2.02
High	10.28
High52	12.51
High52 Date	2025-08-26
High52ch	-19.1%
Low	9.99
Low52	7.89
Low52 Date	2025-05-12
Low52ch	28.26%
Ma50ch	3.48%
Price vs 200-day SMA	-0.07%
RSI	53
RSI Monthly	52.27
RSI Weekly	53.89
Sharpe ratio	0.86x
Sortino ratio	1.65
Total Return	5.11%
Tr YTD	2.02
Tr1m	0.6%
Tr1w	-1.27%
Tr3m	3.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 141.2M
Operating Income Growth	-34.91
Operating Income Growth Q	11.31
Operating Income Growth3 Y	-15.11
Operating Income Growth5 Y	0.54
Operating margin	17.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	375,498,837%
Net Borrowing	194,989,190
Shares Insiders	51.87%
Shares Institutions	5.26%
Shares Out	828,297,745
Shares Qo Q	3.29%
Shares Yo Y	-4.12%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 25.6M
Average Volume	10,830,146.35x
Bv Per Share	2.94
CAPEX	CNY -94.9M
Ch1m	0.6
Ch1w	-1.27
Ch1y	26.82
Ch3m	3.06
Ch3y	-14.69
Ch5y	-9.21
Ch6m	0.4
Change	-1.08%
Change From Open	-1.08
Close	10.23
Days Gap	0
Depreciation Amortization	77,102,988
Dollar Volume	101,992,466.8
Earnings Date	2026-04-29
EBIT	CNY 141.2M
EBITDA	CNY 218.3M
EPS	CNY 0.13
F Score	5
FCF	CNY 25.6M
FCF EV Yield	0.33x
FCF Per Share	CNY 0.03
Financing CF	73,164,827
Fiscal Year End	December
Founded	2,010
Graham Number	2.97961
Graham Upside	-70.56
Income Tax	CNY 468,617
Investing CF	-48,843,290
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Date	2024-07-12
Last Split Type	Forward
Lynch Fair Value	CNY 0.67
Lynch Upside	-93.37
Ma150	9.92
Ma150ch	2%
Ma20	10.09
Ma20ch	0.32%
Net CF	101,367,814
Next Earnings Date	2026-08-24
Open	10.23
P FCF Ratio	327.9
P OCF Ratio	69.61
Payment Date	2025-07-17
Position In Range	44.83
Ppne	1,037,878,104
Price Date	2026-05-08
Price EBITDA	CNY 38.4
Ptbv Ratio	3.78
Relative Volume	0.96x
Revenue	794,796,043x
Tax By Revenue	0.06x
Tax Rate	0.43%
Tr6m	0.4%
Volume	10,078,307

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/603229 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.0%

$0.10 annual per share

Payout ratio

+85.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+34.4%

0 consecutive years of growth

Total shareholder yield

+5.1%

Next ex-dividend date: 2025-07-17

Performance

SHA/603229 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/603229?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.3%

Share of float held by funds and institutions

Insider ownership

+51.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-4.1%

Negative means the company is buying back shares.

Technical

SHA/603229 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.0

Neutral momentum band

Price vs 200-day MA

-0.1%

50/200-day relationship not available

Beta (5Y)

-0.21

Less volatile than the market

Sharpe ratio

0.86

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/603229

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/603229 stock rating?

sha/603229 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/603229 analysis?

The full report lives at /stocks/sha/603229/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/603229?

The latest report frames sha/603229 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/603229 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.